Costs associated with multidrug-resistance in inpatient palliative care

Adelhardt T, Hessemer S, Heckel M, Herbst FA, Stiel S, Ostgathe C, Schöffski O (2019)


Publication Type: Journal article

Publication year: 2019

Journal

Book Volume: 24

Pages Range: 185-190

Journal Issue: 4

DOI: 10.1055/a-0651-6448

Abstract

The study deals with the financial impact of the occurrence of multidrug-resistant pathogens on a palliative care unit of a German university hospital. Aims of the study are an analysis of the cost drivers as well as a cost comparison between MDRO-positive and -negative patients.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Adelhardt, T., Hessemer, S., Heckel, M., Herbst, F.A., Stiel, S., Ostgathe, C., & Schöffski, O. (2019). Costs associated with multidrug-resistance in inpatient palliative care. Gesundheitsökonomie und Qualitätsmanagement, 24(4), 185-190. https://doi.org/10.1055/a-0651-6448

MLA:

Adelhardt, Thomas, et al. "Costs associated with multidrug-resistance in inpatient palliative care." Gesundheitsökonomie und Qualitätsmanagement 24.4 (2019): 185-190.

BibTeX: Download